Inhibitory effect of (-)-saucerneol on osteoclast differentiation and bone pit formation

Phytotherapy Research

Volumn 23, Issue 2, 2009, Pages 185-191

  Kim, Soon Nam ^a,b   Kim, Myung Hee ^a,b   Kim, Young Sup ^a   Ryu, Shi Yong ^a   Min, Yong Ki ^a   Kim, Seong Hwan ^a  

^a Korea Research Institute of Chemical Technology   (South Korea)

^b Chungnam National University   (South Korea)

Author keywords

( ) saucerneol; Bone resorption; Map kinases; Osteoclast differentiation; Osteoporosis

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; COLONY STIMULATING FACTOR 1; LIGNAN DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOCLAST DIFFERENTIATION FACTOR; SAUCERNEOL; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; ACID PHOSPHATASE; FURAN DERIVATIVE; LIGNAN;

ANIMAL CELL; ARTICLE; BONE PIT; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG EFFECT; DRUG ISOLATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; SAURURACEAE; SAURURUS CHINENSIS; ANIMAL; CELL LINE; DRUG ANTAGONISM; ISOLATION AND PURIFICATION; METABOLISM;

SAURURUS CHINENSIS;

ACID PHOSPHATASE; ANIMALS; BONE RESORPTION; CELL LINE; FURANS; GENE EXPRESSION; LIGNANS; MACROPHAGE COLONY-STIMULATING FACTOR; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; OSTEOCLASTS; RANK LIGAND; TRANSCRIPTION FACTORS;

EID: 59449103045     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2581     Document Type: Article

References (42)

1. Asagiri M, Sato K, Usami T, Ochi S, Nishina H, Yoshida H, Morita I, Wagner EF, Mak TW, Serfling E, Takayanagi H. 2005. Autoamplification of NFATd expression determines its essential role in bone homeostasis. J Exp Med 202: 1261-1269.
2. Boyle WJ, Simonet WS, Lacey DL. 2003. Osteoclast differentiation and activation. Nature 423: 337-342.
3. Cella M, Buonsanti C, Strader C, Kondo T, Salmaggi A, Colonna M. 2003. Impaired differentiation of osteoclasts in TREM-2- deficient individuals. J Exp Med 198: 645-651.
4. Chung BS. 1998. Dictionary of Korean folk medicine. Young Lim Sa: Seoul; 813-814.
5. Halleen JM, Raisanen S, Salo JJ, Reddy SV, Roodman GD, Hentunen TA, Lehenkari PP, Kaija H, Vihko P, Vaananen HK. 1999. Intracellular fragmentation of bone resorption products by reactive oxygen species generated by osteoclastic tartrate-resistant acid phosphatase. J Biol Chem 274: 22907-22910.
6. Halleen JM, Raisanen SR, Alatalo SL, Vaananen HK. 2003. Potential function for the ROS-generating activity of TRACP. J Bone Miner Res 18: 1908-1911.
7. Han KY, Yang D, Chang EJ, Lee Y, Huang H, Sung SH, Lee ZH, Kim YC, Kim HH. 2007. Inhibition of osteoclast differentiation and bone resorption by sauchinone. Biochem Pharmacol 74: 911-923.
8. Heymann D, Fortun Y, Rédini F, Padrines M. 2005. Osteolytic bone diseases: physiological of bone resorption effectors as alternative therapeutic tools. Drug Discov Today 10: 242-247.
9. Hsu H, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E, Tan HL, Elliott G, Kelley MJ, Sarosi I, Wang L, Xia XZ, Elliott R, Chiu L, Black, T, Scully S, Capparelli C, Morony S, Shimamoto G, Bass MB, Boyle WJ. 1999. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci 96: 3540-3545.
10. Ikeda F, Nishimura R, Matsubara T, Hata K, Reddy SV, Yoneda T. 2006. Activation of NFAT signal in vivo leads to osteopenia associated with increased osteoclastogenesis and bone- resorbing activity. J Immunol 177: 2384-2390.
11. Ishibashi O, Niwa S, Kadoyama K, Inui T. 2006. MMP-9 antisense oligodeoxynucleotide exerts an inhibitory effect on osteoclastic bone resorption by suppressing cell migration. Life Science 79: 1657-1660.
12. Ishikawa T, Kamiyama M, Tani-Ishii N, Suzuki H, Ichikawa Y, Hamaguchi Y, Momiyama N, Shimada H. 2001. Inhibition of osteoclast differentiation and bone resorption by cathepsin K antisense oligonucleotides. Mol Carcinog 32: 84-91.
13. Iwai K, Iwai K, Koike M, Ohshima S, Miyatake K, Uchiyama Y, Saeki Y, Ishii M. 2007. RGS18 acts as a negative regulator of osteoclastogenesis by modulating the acid-sensing OGR1/NFAT signaling pathway. J Bone Miner Res 22: 1612-1620.
14. Jeong JG, Kim YS, Min YK, Kim SH. 2008. Low concentration of 3-carene stimulates the differentiation of mouse osteoblastic MC3T3-E1 subclone 4 cells. Phytother Res 22: 18-22.
15. Johnson RS, Spiegelman BM, Papaioannou V. 1992. Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell 71: 577-586.
16. Kanno S, Hirano S, Kayama F. 2004. Effects of the phytoestrogen coumestrol on RANK-ligand-induced differentiation of osteoclasts. Toxicology 203: 211-220.
17. Kim HH, Kim JH, Kwak HB, Huang H, Han SH, Ha H, Lee SW, Woo ER, Lee ZH. 2004. Inhibition of osteoclast differentiation and bone resorption by tanshinone IIA isolated from Salvia miltiorrhiza Bunge. Biochem Pharmacol 67: 1647-1656.
18. Kim MH, Kim BT, Min YK, Kim SH. 2006. Profiling signalling pathways of the receptor activator of NF-κB ligand-induced osteoclast formation in mouse monocyte cells, RAW264.7. Amino Acids [Epub ahead of print].
19. Kubanek J, Fenical W, Hay ME, Brown PJ, Lindquist N. 2000. Two antifeedant lignans from the freshwater macrophyte Saururus cernuus. Phytochemistry 54: 281-287.
20. Lee SE, Woo KM, Kim SY, Kim HM, Kwack K, Lee ZH, Kim HH. 2002. The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation. Bone 30: 71-77.
21. Lee WS, Baek YI, Kim JR, Cho KH, Sok DE, Jeong TS. 2004. Antioxidant activities of a new lignan and a neolignan from Saururus chinensis. Bioorg Med Chem Lett 14: 5623-5628.
22. Lee ZH, Kim HH. 2003. Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts. Biochem Biophys Res Commun 305: 211-214.
23. T method. Methods 25: 402-408.
24. Lowe C, Yoneda T, Boyce BF, Chen H, Mundy GR, Soriano P. 1993. Osteopetrosis in Src-deficient mice is due to an autonomous defect of osteoclasts. Proc Natl Acad Sci USA 90: 4485-4489.
25. Matsuo K, Galson DL, Zhao C, Peng L, Laplace C, Wang KZ, Bachler MA, Amano H, Aburatani H, Ishikawa H, Wagner EF. 2004. Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos. J Biol Chem 279: 26475-26480.
26. Matsuo K, Owens JM, Tonko M, Elliott C, Chambers TJ, Wagner EF. 2000. Fos1 is a transcriptional target of c-Fos during osteoclast differentiation. Nat Genet 24: 184-187.
27. Morabito N, Crisafulli A, Vergara C, Gaudio A, Lasco A, Frisina N, D'Anna R, Corrado F, Pizzoleo MA, Cincotta M, Altavilla D, Ientile R, Squadrito F. 2002. Effects of genistein and hormone- replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. J Bone Miner Res 17: 1904-1912.
28. Okada Y, Naka K, Kawamura K, Matsumoto T, Nakanishi I, Fujimoto N, Sato H, Seiki M. 1995. Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV Collagenase = gelatinase B) in osteoclasts: implications for bone resorption. Lab Invest 72: 311-322.
29. Pang M, Martinez AF, Fernandez I, Balkan W, Troen BR. 2007. AP-1 stimulates the cathepsin K promoter in RAW 264.7 cells. Gene 403: 151-158.
30. Park SY, Lee SH, Choi WH, Koh EM, Seo JH, Ryu SY, Kim YS, Kwon DY, Koh WS. 2007. Immunosuppressive lignans isolated from Saururus chinensis. Planta Med 73: 674-678.
31. Putnam SE, Scutt AM, Bicknell K, Priestley CM, Williamson EM. 2007. Natural products as alternative treatments for metabolic bone disorders and for maintenance of bone health. Phytother Res 21: 99-112.
32. Rao KV, Alvarez FM. 1983. Manassantins A/B and saucerneol: novel biologically active lignoids from Saururus cernuus. Tetrahedron Lett 24:4947-4950.
33. Rassi CM, Lieberherr M, Chaumaz G, Pointillart A, Cournot G. 2002. Down-regulation of osteoclast differentiation by daidzein via caspase 3. J Bone Miner Res 17: 630-638.
34. Rozen S, Skaletsky HJ, 2000. Primer3 on the WWW for general users and for biologist programmers. In Bioinformatics Methods and Protocols: Methods in Molecular Biology, Krawetz S, Misener S (eds). Humana Press: Totowa; 365-386.
35. Song SY, Lee I, Park C, Lee H, Hahm JC, Kang WK. 2005. Neolignans from Saururus chinensis inhibit PC-3 prostate cancer cell growth via apoptosis and senescence-like mechanisms. Int J Mol Med 16: 517-523.
36. Soriano P, Montgomery C, Geske R, Bradley A. 1991. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64: 693-702.
37. Sundaram K, Nishimura R, Senn J, Youssef RF, London SD, Reddy SV. 2007. RANK ligand signaling modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiation. Exp Cell Res 313: 168-178.
38. Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, Wagner EF, Mak TW, Kodama T, Taniguchi T. 2002. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 3: 889-901.
39. Wagner EF, Eferl R. 2005. Fos/AP-1 proteins in bone and the immune system. Immunol Rev 208: 126-140.
40. Wang ZQ, Ovitt C, Grigoriadis AE, Mohle-Steinlein U, Ruther U, Wagner EF. 1992. Bone and haematopoietic defects in mice lacking c-fos. Nature 360: 741-745.
41. Yamagishi T, Otsuka E, Hagiwara H. 2001. Reciprocal control of expression of mRNAs for osteoclast differentiation factor and OPG in osteogenic stromal cells by genistein: evidence for the involvement of topoisomerase II in osteoclastogenesis. Endocrinology 142: 3632-3637.
42. Yook CS. 1997. Coloured Medicinal Plants of Korea. Academi Books: Seoul; 556.